| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |